Novel Hydrogel Sealant And Sustained Release Drug Technology Data To Be Presented At The ASCRS Annual Symposium

Ocular Therapeutix, Inc., developers of ophthalmic therapeutic products using a proprietary hydrogel technology, has announced that 11 podium and poster presentations, including clinical data on its ReSure Sealant and sustained release dexamethasone, will be presented at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium in Boston, Massachusetts from April 25-29, 2014.

Help employers find you! Check out all the jobs and post your resume.